3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
3
Phase 1
3
Phase 2
2
Phase 4
1
Phase 2/3
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
118
Breast
8
Gastrointestinal
5
Plasma cell
2
NET
2
Endocrine
2
Dermatologic
2
Thoracic
1
Sarcoma
1
Other
1
Gynecologic
1
Classical hematology
1
Conditions
Anemia
30
Neoplasms
21
Febrile Neutropenia
19
Venous Thromboembolism
12
Precursor Cell Lymphoblastic Leukemia-Lymphoma
6
Neutropenia
5
Leukemia, Myeloid, Acute
5
Colorectal Neoplasms
5
Pulmonary Embolism
4
Myelodysplastic Syndromes
4
Leukemia
4
Fever
4
Anemia, Iron-Deficiency
4
Venous Thrombosis
3
Thrombocytopenia
3
Ovarian Neoplasms
3
Multiple Myeloma
3
Lymphoma, Non-Hodgkin
3
Hematologic Neoplasms
3
Breast Neoplasms
3
Adenocarcinoma
3
Vitamin D Deficiency
2
Uterine Cervical Neoplasms
2
Stomach Neoplasms
2
Sepsis
2
Recurrence
2
Postoperative Complications
2
Lymphoma, Follicular
2
Lymphoma
2
Infections
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 4
×
Prostatic Neoplasms
×
Classical hematology
×
Clear all
NCT03006562
2020-08-05
PREVENTER
Johns Hopkins University
Phase 4
Terminated
501 enrolled
13 charts